>>Tamarisk Technologies, LLC has filed an application for exemption of Phase I and 2 oral insulin clinical trials and has asked the FDA to allow them to enter Phase 3 trials<<

Really? P1 trials establish safe dosages & you think the FDA will allow this to be by-passed?

The FDA rules for insulin trials are well established. MNKD investors know the hurdles that must be cleared. Needless to say, I'm more than sceptical.